Twenty‐year medication use trends in first‐episode bipolar disorder
Open Access
- 12 October 2022
- journal article
- research article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 146 (6), 583-593
- https://doi.org/10.1111/acps.13504
Abstract
Objectives To study the medication use patterns in patients newly diagnosed with bipolar disorder (BD) in Finland during the past 20 years. Methods All persons diagnosed with BD between 1996 and 2018, aged 16-65 years, with no previous BD diagnosis were identified from nationwide Finnish registers (N = 26,395). The point prevalences of medication use were observed up until 5 years after the first diagnosis. Five sub-cohorts according to calendar year of first diagnosis were also formed and the prevalence of medication use was compared between sub-cohorts 3 months after diagnosis. Medication data were modeled with the PRE2DUP-method using dispensing data. Results The prevalence of overall medication use declined during the 5-year follow-up period in the total cohort. The highest prevalence of use was seen 3 months after diagnosis for the three main medication classes-antidepressants (40.8%), antipsychotics (30.8%) and mood stabilizers (29.2%). The prevalence of lithium use varied between 5.9% and 6.5% during the 5 years in the total cohort, and the lowest prevalence of use at 3 months was seen in sub-cohort diagnosed in 2016-2018 (4.1%) versus 12.1% in 1996-2000 sub-cohort. The prevalence of benzodiazepine use was between 12.4% and 13.5% and the prevalence of Z-drugs was between 7.3% and 7.9% during the 5 years. The prevalence of long-acting injectable antipsychotic (LAI) use was the highest in patients diagnosed in 2016-2018, although still only 0.8%. Conclusions (i) The use of antidepressants is too prevalent, (ii) the use of lithium is declining and needs to be increased, and (iii) LAIs are markedly underutilized as compared to their oral counterparts.Keywords
This publication has 37 references indexed in Scilit:
- Lithium and Renal Impairment: A Review on a Still Hot TopicPharmacopsychiatry, 2018
- The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelinesJournal of Affective Disorders, 2017
- Efficacy and Safety of Aripiprazole Once-Monthly in the Maintenance Treatment of Bipolar I DisorderBritish Journal of Psychology, 2017
- Nationwide and population‐based prescription patterns in bipolar disorderBipolar Disorders, 2016
- Lithium vs. valproate vs. olanzapine vs. quetiapine as maintenance monotherapy for bipolar disorder: a population‐based UK cohort study using electronic health recordsWorld Psychiatry, 2016
- Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithiumJournal of Affective Disorders, 2016
- Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney DiseaseJAMA Psychiatry, 2015
- Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based studyActa Neuropsychiatrica, 2015
- From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)BMC Medical Informatics and Decision Making, 2015
- Benzodiazepine Use and Risk of Recurrence in Bipolar DisorderBritish Journal of Psychology, 2010